Nagorney, MD Session II: Adenoma 3:50 – 4:10 PM Imaging Characteristics of Adenomas BachirTaouli, MD 4:10 – 4:30 PM How Molecular and Immunohistochemical Analyses Can Help Us Guide Therapy For Hepatic Adenomas and FNH Jessica Zucman-Rossi, MD, PhD 4:30 – 4:50

PM Resection, Transplantation and Local Regional Therapies For Adenomas Jacques Belghiti, MD 4:50 – 5:10 PM Break Session III: Neuroendocrine Tumors 5:10 – 5:30 PM Imaging Characteristics of Neuroendocrine Tumors Bachir Taouli, MD GW 572016 5:30 – 5:50 PM Current NANETS and ENETS Guidelines for Management Of Neuroendocrine Tumors Diane Reidy, MD 5:50 – 6:10 PM Liver Transplantation for Neuroendocrine Tumors Vincenzo Mazzaferro, MD 6:10 – 6:30 PM Liver Resection and Local Regional Therapies for Neuroendocrine Tumors Timothy M. Pawlik, MD, PhD 6:30 – 6:40 PM Debate: Patients with Neuroendocrine Tumors Will Do Well No Matter What We Do – So Why Treat Them? Vincenzo Mazzaferro, MD 6:40 – 6:50

PM Debate: Patients with Neuroendocrine Tumor Will Do Better With Aggressive Treatment Timothy M. Pawlik, MD, PhD 6:50 – 7:00 PM Closing Remarks AASLD BUSINESS MEETING (MEMBERS ONLY) Saturday, see more November 2 5:15 – 6:15 PM Hall E – General Session Room J. Gregory Fiz, MD, presiding Early Morning Workshops Sunday, November 3 6:45 – 7:45 AM Refer to your luncheon ticket for meeting room location. Sunday Basic Early Morning Workshops Goals and Objectives: Bring together investigators in a specific area of research to discuss their ongoing work. Focus of discussions is on new work and not a review of previous studies. Allow ample time for questions from the audience. EMW-1 Artificial Liver Support Systems Jayanta Roy-Chowdhury, MD and Vicente Arroyo, EMW-2 HCV Replication Andrew H. Talal, MD and Raymond T.

Chung, MD EMW-3 Triggers of Fibrosis in NASH Ariel E. Feldstein, MD and Detlef Schuppan, MD, PhD EMW-4 Cholangiocyte Pathobiology Gianfranco Alpini, PhD and Marco Marzioni, MD EMW-5 Microbiome and the Liver Bernd Schnabl, MD and David Brenner, MD EMW-6 Animal Models of NAFLD Rohit Kohli, MD and Michael R. Charlton, MD anti-PD-1 antibody inhibitor Sunday Clinical Early Morning Workshops Goals and Objectives: Discuss difficult management issues utilizing acknowledged experts in the area. Provide an overview of the current state-of-the-art in each area. Allow ample time for questions from the audience. EMW-7 Imaging of Liver Tumors Claude B. Sirlin, MD and Laura M. Kulik, MD EMW-8 Liver Transplantation for Hepatitis C Xavier Forns, MD and Norah Terrault, MD EMW-9 New Anti-Tumor Agents in Development for HCC Jorge A. Marrero, MD and Josep M.